Citadel Advisors - BELLICUM PHARMACEUTICALS INC ownership

BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 90 filers reported holding BELLICUM PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 2.58 and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of BELLICUM PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$29,000
+107.1%
22,620
+65.1%
0.00%
Q3 2019$14,000
-93.0%
13,700
-88.3%
0.00%
Q2 2019$199,000
-1.0%
116,847
+95.1%
0.00%
Q1 2019$201,000
+38.6%
59,906
+20.9%
0.00%
Q4 2018$145,000
-71.8%
49,568
-40.6%
0.00%
Q3 2018$514,000
-64.5%
83,468
-57.4%
0.00%
-100.0%
Q2 2018$1,447,000
+0.6%
196,002
-10.6%
0.00%0.0%
Q1 2018$1,438,000
+14.2%
219,223
+46.4%
0.00%
Q4 2017$1,259,000
-57.1%
149,744
-41.0%
0.00%
-100.0%
Q3 2017$2,932,000
+147.6%
253,936
+150.5%
0.00%
+100.0%
Q2 2017$1,184,000
+56.0%
101,386
+65.0%
0.00%
Q1 2017$759,000
+181.1%
61,430
+210.3%
0.00%
Q4 2016$270,000
+0.4%
19,800
+46.7%
0.00%
Q3 2016$269,000
+80.5%
13,500
-15.0%
0.00%
Q1 2016$149,000
-72.2%
15,888
-39.9%
0.00%
-100.0%
Q4 2015$536,000
-94.1%
26,419
-95.7%
0.00%
-88.9%
Q3 2015$9,012,000
-5.7%
620,225
+38.0%
0.01%
+12.5%
Q2 2015$9,561,000
+75.4%
449,488
+91.1%
0.01%
+60.0%
Q1 2015$5,451,000
-30.1%
235,249
-30.5%
0.01%
-37.5%
Q4 2014$7,799,000338,5260.01%
Other shareholders
BELLICUM PHARMACEUTICALS INC shareholders Q1 2018
NameSharesValueWeighting ↓
EMORY UNIVERSITY 95,215$1,297,0001.28%
Baker Brothers Advisors 4,865,647$66,270,0000.65%
Eventide Asset Management 250,000$3,405,0000.22%
MCDANIEL TERRY & CO 76,112$1,037,0000.22%
SUFFOLK CAPITAL MANAGEMENT LLC 82,538$1,124,0000.15%
QVT Financial LP 337,923$4,603,0000.14%
KENNEDY CAPITAL MANAGEMENT LLC 478,465$6,517,0000.11%
Vident Investment Advisory, LLC 47,157$642,0000.08%
Tekla Capital Management LLC 60,000$817,0000.04%
First Eagle Investment Management, LLC 775,254$10,559,0000.03%
View complete list of BELLICUM PHARMACEUTICALS INC shareholders